MeSH term
Frequency | Condition_Probility | Adult | 16 | 0.0 |
Female | 24 | 0.0 |
Humans | 53 | 0.0 |
Japan | 2 | 0.0 |
Male | 24 | 0.0 |
Membrane Proteins/*genetics | 30 | 3.0 |
Neurofibrillary Tangles/pathology | 4 | 7.0 |
Pedigree | 14 | 0.0 |
Point Mutation/genetics | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 40 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
Senile Plaques/pathology | 4 | 11.0 |
Magnetic Resonance Imaging | 5 | 0.0 |
Middle Aged | 24 | 0.0 |
*Mutation | 7 | 0.0 |
Neuropsychological Tests | 6 | 2.0 |
Age of Onset | 11 | 0.0 |
Amino Acid Sequence | 7 | 0.0 |
Base Sequence | 8 | 0.0 |
DNA/chemistry/genetics | 3 | 0.0 |
DNA Mutational Analysis | 14 | 0.0 |
Dementia/*genetics | 2 | 5.0 |
Fatal Outcome | 4 | 0.0 |
Molecular Sequence Data | 9 | 0.0 |
Mutation | 11 | 0.0 |
Alzheimer Disease/*genetics | 17 | 5.0 |
Apolipoproteins E/genetics | 7 | 2.0 |
Chromosome Mapping | 4 | 0.0 |
Chromosomes, Human, Pair 12/genetics | 2 | 2.0 |
Genetic Screening | 2 | 0.0 |
Brain/pathology | 3 | 0.0 |
Chromosomes, Human, Pair 14 | 2 | 1.0 |
Exons | 3 | 0.0 |
Mutation/genetics | 2 | 0.0 |
Amino Acid Substitution/genetics | 2 | 0.0 |
Amyloid beta-Protein Precursor/genetics | 9 | 18.0 |
Leucine/genetics | 2 | 3.0 |
Aged | 13 | 0.0 |
Aged, 80 and over | 5 | 0.0 |
Case-Control Studies | 5 | 0.0 |
*Genetic Predisposition to Disease | 3 | 0.0 |
Polymorphism, Genetic | 3 | 0.0 |
Risk Factors | 5 | 0.0 |
Animals | 12 | 0.0 |
Membrane Proteins/genetics | 8 | 2.0 |
Alzheimer Disease/epidemiology/*genetics | 5 | 8.0 |
Amino Acid Substitution | 5 | 0.0 |
Gene Frequency | 7 | 0.0 |
Point Mutation | 3 | 0.0 |
Polymorphism, Restriction Fragment Length | 4 | 0.0 |
Polymorphism, Single-Stranded Conformational | 4 | 0.0 |
Proteins/*genetics | 2 | 0.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
Alleles | 4 | 0.0 |
Gene Deletion | 2 | 0.0 |
Genotype | 5 | 0.0 |
*Polymorphism, Genetic | 4 | 0.0 |
Brain/*pathology | 3 | 1.0 |
Confidence Intervals | 2 | 0.0 |
Comparative Study | 3 | 0.0 |
Mice | 6 | 0.0 |
Disease Progression | 2 | 0.0 |
Prions/*genetics | 2 | 3.0 |
Regression Analysis | 2 | 0.0 |
Mutation, Missense/*genetics | 3 | 1.0 |
Mutation/*genetics | 2 | 0.0 |
Valine/genetics | 2 | 2.0 |
Cell Line | 5 | 0.0 |
Membrane Proteins/*genetics/metabolism | 2 | 1.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Transfection | 4 | 0.0 |
*Age of Onset | 3 | 13.0 |
Genes, Regulator/genetics | 2 | 4.0 |
Introns/genetics | 2 | 0.0 |
Linkage Disequilibrium | 2 | 0.0 |
Polymorphism, Genetic/*genetics | 2 | 0.0 |
Promoter Regions (Genetics)/*genetics | 2 | 0.0 |
Tandem Repeat Sequences/genetics | 2 | 4.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Heterozygote | 2 | 0.0 |
Exons/genetics | 2 | 0.0 |
Alzheimer Disease/*genetics/metabolism | 2 | 6.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Family Health | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Amyloid beta-Protein Precursor/*genetics | 2 | 3.0 |
